Skip to content
healthcare.dev

Bupivacaine

NDC 57884-3252, Bupivacaine, injection, suspension, liposomal, from Jiangsu Hengrui Pharmaceuticals Co., Ltd..

Product NDC
57884-3252
Status
Listed
Labeler
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INFILTRATION
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214348
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57884-3252 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPIVACAINE13.3 mg/mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]

Package NDCNDC-11Package
57884-3252-15788432520110 VIAL in 1 CARTON (57884-3252-1) / 20 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0af296bb-1599-4b35-b66b-994924d3e898

Use it

Look up 57884-3252 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57884-3252 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57884-3252. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.